1. Home
  2. ATNM vs AP Comparison

ATNM vs AP Comparison

Compare ATNM & AP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

N/A

Current Price

$1.16

Market Cap

36.8M

Sector

Health Care

ML Signal

N/A

Logo Ampco-Pittsburgh Corporation

AP

Ampco-Pittsburgh Corporation

N/A

Current Price

$9.56

Market Cap

138.0M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ATNM
AP
Founded
2000
1929
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Fluid Controls
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
36.8M
138.0M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ATNM
AP
Price
$1.16
$9.56
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
109.4K
289.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
30.60
N/A
EPS
N/A
N/A
Revenue
$81,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$1.75
52 Week High
$1.95
$9.97

Technical Indicators

Market Signals
Indicator
ATNM
AP
Relative Strength Index (RSI) 48.69 61.62
Support Level $1.02 $2.39
Resistance Level $1.71 $9.69
Average True Range (ATR) 0.07 0.72
MACD 0.02 -0.06
Stochastic Oscillator 62.79 78.49

Price Performance

Historical Comparison
ATNM
AP

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About AP Ampco-Pittsburgh Corporation

Ampco-Pittsburgh Corp is manufacturing and selling engineered, specialty metal products and customized equipment. It operates in two business segments namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, and other metals whereas, the Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, and Buffalo Pumps. The company generates a majority of its revenue from the Forged and Cast Engineered Products segment. It has a business presence in the United States and other countries.

Share on Social Networks: